The impact of Human Immunodeficiency Virus type 1 status on Human Papillomavirus (HPV) prevalence and HPV antibodies in serum and cervical secretions

Journal of Infectious Diseases

Volumn 182, Issue 4, 2000, Pages 1239-1242

  Marais, Dianne J ^a   Vardas, Eftyhia ^b   Ramjee, Gita ^b   Allan, Bruce ^a   Kay, Patti ^a   Rose, R C ^c   Williamson, Anna Lise ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION RISK; MAJOR CLINICAL STUDY; PAPILLOMA VIRUS; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS PARTICLE;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; DNA, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMAN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MIDDLE AGE; PAPILLOMAVIRUS, HUMAN; PAPOVAVIRIDAE INFECTIONS; PREVALENCE; PROSTITUTION; SEROEPIDEMIOLOGIC STUDIES; SOUTH AFRICA; SUPPORT, NON-U.S. GOV'T; TUMOR VIRUS INFECTIONS; VAGINAL SMEARS;

EID: 0033800923     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315815     Document Type: Article

References (15)

1. A matched prospective study of human immunodeficiency virus serostatus, human papillomavirus DNA, and cervical lesions detected by cytology and colposcopy
2. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women
3. Human immunodeficiency virus infection in vitro activates naturally integrated human papillomavirus type 18 and induces synthesis of the Ll capsid protein
4. Systemic immunosuppression by HIV infection influences HPV transcription and thus local immune responses in condyloma acuminatum
5. Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men
6. HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer rates
7. Sexually transmitted infections amongst sex workers in KwaZulu-Natal, South Africa
8. Seroresponses to human papillomavirus types 16, 18, 31, 33 and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia
9. Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNA
10. Differential kinetics and distribution of antibodies in serum and nasal secretions after nasal and oral vaccination of humans
11. Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects
12. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrast with normal or impaired IgA local response in HIV infection
13. Abnormalities of B-cell activation and immunoregulation with acquired immunodeficiency syndrome
14. High-level ability of secretory IgA to block HIV type 1 transytosis: Contrasting secretory IgA and IgG responses to glycoprotein 160
15. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II: Systemic but not local IgA responses correlate with clearance of HPV-16